A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Clinical trial NCT06742996 · RECRUITING
Trial details
- NCT number
- NCT06742996
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-05
- Primary completion
- 2028-08-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.